Muvon
First in Human trial results published, demonstrating safety and feasibility of MUVON's SUI Therapy
First in Human (FIH) trial results of MUVON's regenerative therapy for the treatment of stress urinary incontinence are now officially...
top of page
Search
Muvon
- Jan 27, 2022
- 1 min
Translation and automation hurdles for cell therapies
Informative article published in BioInsights, written by our CSO Jenny Prange and our innovation manager Beatrix Rauch Schmid. This...
215 views0 comments
Muvon
- Jan 20, 2021
- 1 min
Modern Therapy of Urinary Incontinence Using Muscle Stem Cells (Article in German)
Abstract: Urinary incontinence affects a large number of patients, and the cost of treatment continues to rise with the demographic...
272 views0 comments
Muvon
- Jun 26, 2020
- 1 min
Muscle Precursor Cells for the Restoration of Irreversibly Damaged Sphincter Function
Abstract Multiple modalities, including injectable bulking agents and surgery, have been used to treat stress urinary incontinence....
153 views0 comments
Muvon
- Jun 25, 2020
- 1 min
The role of donor age and gender in the success of human muscle precursor cell transplantation
Abstract Autologous cell transplantation for the treatment of muscle damage is envisioned to involve the application of muscle precursor...
50 views0 comments
bottom of page